> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Clears AngioVue Ocular Imaging System
- URL: https://www.fdaweb.com/fda-clears-angiovue-ocular-imaging-system/
- Published: 2016-02-12T12:00:00.000Z
- Updated: 2026-09-15T02:35:27.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5134752

> FDA has cleared an Optovue 510(k) for the AngioVue Imaging System, a dyeless technique for quickly visualizing abnormal blood vessels in the retina to help physicians determine an appropriate treatment course. “In less than three seconds, the AngioVue System acquires a single image that complements the current angiography imaging standard, fluorescein angiography,” the company says. The device allows users to image the motion of scattering particles, such as erythrocytes (red blood cells), using sequential Optical Coherence Tomography cross-sectional scans, which are repeated at the same location on the retina. “Capturing the dynamic motion of the erythrocytes allows a 3D visualisation of the perfused vasculature and micro vasculature of the retina,” it says. “Unlike other imaging methods, which utilise contrast agents, AngioVue allows visualisation of specific layers of the retina, without the blurring or obscuring effects of staining or pooling.”